Evidence map›Paper›PMID 33968148›Full record

ArticleInterdisciplinary perspectives on infectious diseases2021

C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients.

Mahmoud Sadeghi-Haddad-Zavareh, Masomeh Bayani, Mehran Shokri, Soheil Ebrahimpour, Arefeh Babazadeh, Rahele Mehraeen, Emadoddin Moudi, Ali Rostami, Mohammad Barary, Akram Hosseini and 2 more

Abstract read
In one paragraph

Article in Interdisciplinary perspectives on infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Severity of oxidative stress as a hallmark in COVID-19 patients.European journal of medical research · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mahmoud Sadeghi-Haddad-ZavarehInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0001-8701-7267
Masomeh BayaniInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0003-3044-1168
Mehran ShokriInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0002-5216-618X
Soheil EbrahimpourInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0003-3204-0448
Arefeh BabazadehInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0002-1362-7203
Rahele MehraeenDepartment of Radiology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0002-1256-8790
Emadoddin MoudiClinical Research Development Center, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0002-5151-1981
Ali RostamiInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0002-1358-1321
Mohammad BararyStudent Research Committee, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0001-8733-9370
Akram HosseiniDepartment of Pathology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0001-8697-9122
Ali BijaniDepartment of Radiology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0003-2233-8726
Mostafa JavanianInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0002-2771-4578

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While some biomolecules have been explored to identify potential biomarkers for the prognosis of COVID-19 patients, there is no reliable prognostic indicator of the disease progression and severity. We aimed to evaluate the ability of the C-reactive protein (CRP) to predict COVID-19 infection outcome. This retrospective study was conducted on 429 patients diagnosed with COVID-19 between March 30, 2020, and April 30, 2020. The study population was divided into severe (

Identifiers

PMID33968148
PMCPMC8083820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.